[ON EXPERIENCE WITH INTERNAL (COMBINED CYTOSTATIC-RESISTANCE INCREASING) CANCER THERAPY].
D000970:Antineoplastic Agents; D001317:Austria; D006728:Hormones; D006801:Humans; D007106:Immune Sera; D012157:Mononuclear Phagocyte System; D009369:Neoplasms / Q000453:epidemiology* / Q000628:therapy*; D010952:Plasma Substitutes; D011506:Proteins; D014815:Vitamins
D000970:Antineoplastic Agents; D006728:Hormones; D007106:Immune Sera; D010952:Plasma Substitutes; D011506:Proteins; D014815:Vitamins
ANTINEOPLASTIC AGENTS; AUSTRIA; HORMONES; IMMUNE SERUMS; NEOPLASM STATISTICS; NEOPLASM THERAPY; PLASMA SUBSTITUTES; PROTEINS; RETICULOENDOTHELIAL SYSTEM; VITAMINS
ZUR DURCHFUEHRUNG EINER INTERNISTISCHEN (KOMBINIERTEN ZYTOSTATISCHEN-RESISTENZSTEIGERNDEN) KARZINOMTHERAPIE.